Chronic Lymphocytic Leukaemia and other B-Cell Disorders

Postgraduate Haematology: Fifth Edition

Volumn , Issue , 2007, Pages 619-643

  Catovsky, Daniel ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Bone marrow examination; Chronic lymphocytic leukaemia; Immunoblastic transformation or richter's syndrome; Prognostic factors; VH mutations

Indexed keywords

EID: 43549125165     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987056.ch38     Document Type: Chapter

References (35)

1. Bennett JM, Catovsky D, Daniel MT et al. (1989) Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. Journal of Clinical Pathology 42: 567-84.
2. Binet JL, Auquier A, Dighiero G et al. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198-206.
3. Bosanquet AG, Johnson SA, Richards SM (1999) Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay. British Journal of Haematology 106: 71-7.
4. Caligaris-Cappio F (2003) Role of the microenvironment in chronic lymphocytic leukaemia. British Journal of Haematology 123: 380-8.
5. CLL Trialists' Collaborative Group (1999) Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. Journal of the National Cancer Institute 91: 861-8.
6. Cheson BD, Bennett JM, Grever M et al. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87: 4990-7.
7. Crespo M, Bosch F, Villamor N et al. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. New England Journal of Medicine 18: 1764-75.
8. Damle RN, Wasil T, Fais F et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94: 1840-7.
9. Del Giudice I, Matutes E, Morilla R et al. (2004) The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica 89: 303-8.
10. Delgado J, Matutes E, Morilla AM et al. (2003) Diagnostic significance of CD20 and FMC7 expression in B-cell disorders. American Journal of Clinical Pathology 120: 754-9.
11. Dewald GW, Brockman SR, Paternoster SF et al. (2003) Chromosome anomalies detected by interphase fluorescence in-site hybridization:correlation with significant biological features of B-cell chronic lymphocytic leukaemia. British Journal of Haematology 121: 287-95.
12. Dyer MJ, Oscier DG (2002) The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia 16: 973-84.
13. Franco V, Florena AM, Iannitto E (2003) Splenic marginal zone lymphoma. Blood 101: 2464-72.
14. Galton DAG, Goldman JM, Wiltshaw E et al. (1974) Prolymphocytic leukaemia. British Journal of Haematology 27: 7-23.
15. Garcia-Marco JA, Price CM, Ellis J et al. (1996) Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia. Leukemia 10: 1705-11.
16. Giles FJ, Bekele BN, O'Brien S et al. (2003) A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression. British Journal of Haematology 121: 578-85.
17. Hamblin TJ, Davis Z, Gardiner A, Oscier D, Stevenson FK (1999) Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94: 1848-54.
18. Hedenus M, Adriansson M, San Miguel J et al. (2003) Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double blinded placebocontrolled study. British Journal of Haematology 122: 394-403.
19. Houlston RS, Sellick G, Yuille M, Matutes E, Catovsky D (2003) Causation of chronic lymphocytic leukemia-insights from familial disease. Leukemia Research 27: 871-6.
20. Jaffe ES, Harris NL, Stein H et al. (eds) (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. IARC Press, Lyon.
21. Keating MJ, Kantarjian H, O'Brien S et al. (1991) Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. Journal of Clinical Oncology 9: 44-9.
22. Krober A, Seiler T, Benner A et al. (2002) VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100: 1410-16.
23. Lampert IA, Wotherspoon A, Van Noorden, Hasserjian RP (1999) High expression of CD23 in the proliferation centres of chronic lymphocytic leukaemia in lymph nodes and spleen. Human Pathology 30: 648-54.
24. Matutes E, Owusu-Ankomah K, Morilla R et al. (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8: 1640-5.
25. Matutes E, Parry-Jones N, Brito-Babapulle V et al. (2004) The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients. Leukemia and Lymphoma 45: 2007-15.
26. Moreau EJ, Matutes E, A'Hern RP et al. (1997) Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). American Journal of Clinical Pathology 108: 378-82.
27. Orchard J, Garand R, Davis Z et al. (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101: 4975-81.
28. Parry-Jones N, Matutes E, Gruszka-Westwood AM et al. (2003) Prognostic features of splenic lymphoma with villous lymphocytes:a report on 129 patients. British Journal of Haematology 120: 759-64.
29. Rai KR, Sawitsky A, Cronkite E et al. (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219-34.
30. Rawstron AC, Yuille MR, Fuller J et al. (2002) Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood 100: 2289-90.
31. Ruchlemer R, Wotherspoon AC, Thompson JN et al. (2002) Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia. British Journal of Haematology 118: 952-8.
32. Staudt LM (2003) Molecular diagnosis of the hematologic cancers. New England Journal of Medicine 348: 1777-85.
33. Thomas R, Ribeiro I, Shepherd P et al. (2002) Spontaneous clinical regression in chronic lymphocytic leukaemia. British Journal of Haematology 116: 341-5.
34. Thornton PD, Gruszka-Westwood AM, Hamoudi RA et al. (2003) Characterization of TP53 abnormalities in chronic lymphocytic leukaemia. The Haematology Journal 5: 47-54.
35. Wiestner A, Rosenwald A, Barry TS et al. (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101: 4944-51.